SARS-CoV-2-IN-60
SARS-CoV-2-IN-60 (compound 5a) is an S-adenosylmethionine (SAM) -competitive and irreversible SARS-CoV-2 nsp16-nsp10 methyltransferase activity inhibitor with an IC50 of 9 μM and a Ki of 26 μM. SARS-CoV-2-IN-60 can specifically occupy a newly identified pocket adjacent to the SAM-binding site on nsp16. SARS-CoV-2-IN-60 has the potential for pan-coronavirus therapeutics[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-60.html
Purity
99.22
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=CC=C(/C=C/C2=NC(O)=NC(C(F)(F)F)=C2)C(Cl)=C1
Molecular Formula
C13H7Cl2F3N2O
Molecular Weight
335.11
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Kallikrein 9, NT (Kallikrein-9, KLK9, Kallikrein Related Peptidase 9, Kallikrein-like Protein 3, KLKL3, KLK-L3) (MaxLight 750) discontinued
